Cardiac Science’s voluntary field correction for a suite of automated external defibrillators got Class I recall status from the FDA over concerns that a failed component may keep the device from providing life-saving therapy during a heart attack.
The company’s PowerHeart G3 AEDs are mobile devices, often found in hospitals, schools or physicians’ offices, intended to be used by trained personnel to deliver defibrillation therapy to someone suffering sudden cardiac arrest.